Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy
This randomized pilot clinical trial studies the effects of meditation-based breathing training on patients' control of their breathing patterns and breathing-related movement, as well as on their psychological distress and treatment experience during radiation therapy. Meditation-based breathing training may decrease breathing-related movement and the amount of stress by improving breathing patterns in patients with abdominal or lung cancer undergoing radiation therapy.
Checked against the public recordLast updated May 18, 2018 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Other
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Albert Einstein College of Medicine
- Interventions being studied
- Other: Educational Intervention; Other: Meditation Therapy; Other: Questionnaire Administration
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * PHASE I - PATIENTS: All patients with abdominal tumors who have undergone at least 4 respiratory-gated radiotherapy treatments * PHASE I - PATIENTS: Full comprehension of English language * PHASE I - STAFF: All staff who have overseen the delivery of respiratory-gated radiotherapy for at least 6 months * PHASE I - STAFF: Full comprehension of English language * PHASE II: All patients with abdominal or lung tumors undergoing a respiratory gating simulation * PHASE II: Karnofsky performance status \> 60% * PHASE II: Life expectancy \> 3 months * PHASE II: No prior radiotherapy to the abdomen/lung * PHASE II: Full comprehension of English language Exclusion Criteria: * PHASE I - PATIENTS: Inability to comprehend English language interview questions * PHASE I - STAFF: Inability to comprehend English language interview questions * PHASE II: Karnofsky performance status \< 60% * PHASE II: Prior radiotherapy to the abdomen/lung * PHASE II: Evidence of progressive or untreated gross disease outside of the abdomen/lung * PHASE II: Inability to comprehend English language breathing exercise instructions * PHASE II: Concurrent diagnosis of a significant respiratory disorder which requires the use of oxygen
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Albert Einstein College of MedicineThe Bronx, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 18, 2018. Always confirm current availability with the study team.